Genetics of Parkinson's disease.
暂无分享,去创建一个
[1] Chuong B. Do,et al. Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.
[2] David W. Miller,et al. α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication , 2004, Neurology.
[3] N. Pedersen,et al. Heritability of Parkinson disease in Swedish twins: a longitudinal study , 2011, Neurobiology of Aging.
[4] S. Pappatà,et al. Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early‐Onset Parkinsonism , 2013, Human mutation.
[5] Z. Wszolek,et al. Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. , 2009, Parkinsonism & related disorders.
[6] P. Pramstaller,et al. Heterozygous PINK1 mutations: A susceptibility factor for Parkinson disease? , 2006, Movement disorders : official journal of the Movement Disorder Society.
[7] A. Kakita,et al. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia. , 2008, Archives of neurology.
[8] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[9] M. Farrer,et al. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries , 2006, Movement disorders : official journal of the Movement Disorder Society.
[10] A. Varrone,et al. PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism , 2006, Movement disorders : official journal of the Movement Disorder Society.
[11] M. Farrer,et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication , 2007, Neurology.
[12] J Q Trojanowski,et al. A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.
[13] Changan Jiang,et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.
[14] Marc N. Offman,et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.
[15] J. Schulz,et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.
[16] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[17] K. Lohmann,et al. Clinical and demographic characteristics of PINK1 mutation carriers—A meta‐analysis , 2010, Movement disorders : official journal of the Movement Disorder Society.
[18] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[19] Hong Jiang,et al. Mutations in NR4A2 associated with familial Parkinson disease , 2003, Nature Genetics.
[20] A. Bonnet,et al. EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants? , 2012, Neurobiology of Aging.
[21] R. Lipton,et al. Olfactory dysfunction in LRRK2 G2019S mutation carriers , 2011, Neurology.
[22] J. Trojanowski,et al. Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery , 2006, Neuron.
[23] Christine Klein,et al. Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes , 2005 .
[24] P. Pollak,et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers , 2012, Neurology.
[25] R. Barker,et al. A case of late onset sporadic Parkinson’s disease with an A53T mutation in α-synuclein , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[26] P. Bauer,et al. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism , 2005, European Journal of Human Genetics.
[27] D. Elstein,et al. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2005, The New England journal of medicine.
[28] A. Lang,et al. Deciphering the role of heterozygous mutations in genes associated with parkinsonism , 2007, The Lancet Neurology.
[29] Michel Goedert,et al. Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.
[30] F. Brancati,et al. Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum , 2007, Human mutation.
[31] Timothy Lynch,et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. , 2005, American journal of human genetics.
[32] D. Krainc,et al. Zn²⁺ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. , 2014, Human molecular genetics.
[33] N. Brüggemann,et al. Mortalin mutations are not a frequent cause of early-onset Parkinson disease , 2013, Neurobiology of Aging.
[34] C. Klein,et al. Impact of recent genetic findings in Parkinson's disease , 2007, Current opinion in neurology.
[35] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[36] M. Farrer,et al. Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. , 2009, Parkinsonism & related disorders.
[37] P. Pástor,et al. PINK1-linked parkinsonism is associated with Lewy body pathology. , 2010, Brain : a journal of neurology.
[38] N. Brüggemann,et al. Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts , 2011, PloS one.
[39] M. Farrer,et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. , 1999, Human molecular genetics.
[40] Alexandra Durr,et al. How much phenotypic variation can be attributed to parkin genotype? , 2003, Annals of neurology.
[41] H. Ischiropoulos,et al. Molecular Neurodegeneration BioMed Central Review , 2009 .
[42] V. Lee,et al. Modeling Lewy pathology propagation in Parkinson's disease. , 2014, Parkinsonism & related disorders.
[43] L. Racacho,et al. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[44] Matthew J. Farrer,et al. LRRK2 in Parkinson's disease: protein domains and functional insights , 2006, Trends in Neurosciences.
[45] W. Oyen,et al. FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.
[46] N. Quinn,et al. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide , 2013, Movement disorders : official journal of the Movement Disorder Society.
[47] Yih-Ru Wu,et al. LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi‐center pooled analysis , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[48] M. Ronaghi,et al. Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.
[49] Christos Proukakis,et al. A novel α-synuclein missense mutation in Parkinson disease , 2013, Neurology.
[50] M. Farrer,et al. VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.
[51] Janel O. Johnson,et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. , 2004, Archives of neurology.
[52] M. Polymeropoulos,et al. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. , 1999, American journal of human genetics.
[53] M. Farrer,et al. Low frequency of α‐synuclein mutations in familial Parkinson's disease , 1998, Annals of neurology.
[54] D. Dickson,et al. Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation , 2010, Neurodegenerative Diseases.
[55] C. Klein,et al. The many faces of alpha‐synuclein mutations , 2013, Movement disorders : official journal of the Movement Disorder Society.
[56] V. Álvarez,et al. Mutational screening of the mortalin gene (HSPA9) in Parkinson’s disease , 2009, Journal of Neural Transmission.
[57] T. Foroud,et al. Mutations in DJ-1 are rare in familial Parkinson disease , 2006, Neuroscience Letters.
[58] D. Eliezer,et al. Structural effects of Parkinson's disease linked DJ‐1 mutations , 2008, Protein science : a publication of the Protein Society.
[59] E. Tolosa,et al. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the α-synuclein gene in early onset patients , 1997, Neuroscience Letters.
[60] A. Abeliovich,et al. The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology , 2006, Neuron.
[61] A. Albanese,et al. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease , 2005, Neurology.
[62] P. Stanzione,et al. Late onset sporadic Parkinson's disease caused by PINK1 mutations: Clinical and functional study , 2008, Movement disorders : official journal of the Movement Disorder Society.
[63] A. Destée,et al. Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. , 2009, Archives of neurology.
[64] A. Lang,et al. Motor and non-motor fluctuations. , 2007, Handbook of clinical neurology.
[65] D. Perl. The neuropathology of parkinsonism. , 2007, Handbook of clinical neurology.
[66] Mark A. Wilson,et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[67] Y. Sohn,et al. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease , 2008, Neurogenetics.
[68] K. Lohmann,et al. Genetics of Parkinson disease and other movement disorders. , 2012, Current opinion in neurology.
[69] W. Dauer,et al. Leucine-rich repeat kinase 2 for beginners: six key questions. , 2012, Cold Spring Harbor perspectives in medicine.
[70] A Dürr,et al. Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[71] C. Ki,et al. The Ala53Thr mutation in the α‐synuclein gene in a Korean family with Parkinson disease , 2007 .
[72] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[73] J. Haines,et al. The α-synuclein gene is not a major risk factor in familial Parkinson disease , 1999, Neurogenetics.
[74] L. Honig,et al. Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Aβ accumulation , 2008, Proceedings of the National Academy of Sciences.
[75] Apolipoprotein E genotype in familial Parkinson's disease. The French Parkinson's Disease Genetics Study Group. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[76] M. Farrer,et al. LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? , 2006, Trends in molecular medicine.
[77] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[78] Marc Cruts,et al. Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.
[79] P. Heutink,et al. The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. , 2003, Human molecular genetics.
[80] M. Farrer,et al. Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseSYMBOL , 2008, Neurology.
[81] M. Feany,et al. α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease , 2005, Nature Neuroscience.
[82] M. Pericak-Vance,et al. Genetic complexity and Parkinson's disease. Deane Laboratory Parkinson Disease Research Group. , 1997, Science.
[83] Philippe Amouyel,et al. α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.
[84] K. Marder,et al. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease , 2006, Neurology.
[85] A. Brice,et al. α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.
[86] E. Tolosa,et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.
[87] A. Brice. Genetics of Parkinson's disease: LRRK2 on the rise. , 2005, Brain : a journal of neurology.
[88] J. Trojanowski,et al. Biochemical and pathological characterization of Lrrk2 , 2006, Annals of neurology.
[89] F. Binkofski,et al. Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit , 2010, Neurology.
[90] Y. Agid,et al. Genetic complexity and Parkinson's disease. , 1997, Science.
[91] J. Langston,et al. Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. , 2009, Neurotoxicology.
[92] E. Sidransky,et al. Heterozygosity for a Mendelian disorder as a risk factor for complex disease , 2006, Clinical genetics.
[93] Kazuko Hasegawa,et al. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family , 2005, Annals of neurology.
[94] Janna H. Neltner,et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology , 2012, Neurology.
[95] E. Sidransky,et al. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) , 2008, Human mutation.
[96] R. Youle,et al. Mechanisms of mitophagy , 2010, Nature Reviews Molecular Cell Biology.
[97] C. Klein,et al. The genetics of Parkinson disease: implications for neurological care , 2006, Nature Clinical Practice Neurology.
[98] A. Lang,et al. Fixing the broken system of genetic locus symbols , 2012, Neurology.
[99] D. Hernandez,et al. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. , 2003, Human molecular genetics.
[100] G. Dorn,et al. PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.
[101] A. Tolun,et al. DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability. , 2013, Parkinsonism & related disorders.
[102] M. Farrer,et al. Genomic investigation of α‐synuclein multiplication and parkinsonism , 2008, Annals of neurology.
[103] C. Klein,et al. Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes , 2005, Neurology.
[104] Xin Zhao,et al. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[105] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[106] A. Ziegler,et al. Next-generation phenotyping using the parkin example: time to catch up with genetics. , 2013, JAMA neurology.
[107] C. Goetz,et al. History of Parkinson's disease. , 2007, Handbook of clinical neurology.
[108] D. Elstein,et al. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. , 2006, Blood cells, molecules & diseases.
[109] A. López de Munain,et al. LRRK2 G2019S and R1441G mutations associated with Parkinson’s disease are common in the Basque Country, but relative prevalence is determined by ethnicity , 2009, neurogenetics.
[110] J. Ioannidis,et al. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study , 2011, The Lancet Neurology.
[111] E. Eisenberg,et al. Multiple Roles of Auxilin and Hsc70 in Clathrin‐Mediated Endocytosis , 2007, Traffic.
[112] G. Schellenberg,et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. , 2008, Archives of neurology.
[113] Nadezhda T. Doncheva,et al. Profiling of Parkin-Binding Partners Using Tandem Affinity Purification , 2013, PloS one.
[114] F. Binkofski,et al. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit? , 2006, Archives of neurology.
[115] J. Burgunder,et al. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias , 2009, European journal of neurology.
[116] E. Sidransky,et al. Glucocerebrosidase mutations in subjects with parkinsonism. , 2004, Molecular genetics and metabolism.
[117] P. Vieregge,et al. Attitudes of young patients with Parkinson's disease towards possible presymptomatic and prenatal genetic testing. , 2001, Genetic counseling.
[118] Ramsay J. Hunt. A SYSTEM DISEASE OF THE PARALYSIS AGITANS TYPE, CHARACTERIZED BY ATROPHY OF THE MOTOR CELLS OF THE CORPUS STRIATUMA CONTRIBUTION TO THE FUNCTIONS OF THE CORPUS STRIATUM , 1917 .
[119] T. Ikeuchi,et al. PROMINENT PSYCHIATRIC SYMPTOMS AND GLUCOSE HYPOMETABOLISM IN A FAMILY WITH A SNCA DUPLICATION , 2008, Neurology.
[120] Jan Gründemann,et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.
[121] J. Stockman. Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .
[122] Bonifati,et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.
[123] Matthew J. Farrer,et al. Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .
[124] N. Hattori,et al. Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism , 2005, Neurology.
[125] M. Polymeropoulos,et al. Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.
[126] R. Hilker,et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers , 2005, Annals of neurology.
[127] J W Langston,et al. Parkinson disease in twins: an etiologic study. , 1999, JAMA.
[128] I. Alafuzoff,et al. α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia , 2005, Annals of neurology.
[129] K. Marder,et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. , 2010, Archives of neurology.
[130] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[131] C. Klein,et al. Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder , 2007, Neurology.
[132] M. Farrer,et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients , 2005, Neuroscience Letters.
[133] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[134] J. Hardy,et al. Parkin disease: a clinicopathologic entity? , 2013, JAMA neurology.
[135] M. Memo,et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.
[136] A. Singleton,et al. Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease , 2006 .
[137] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[138] A. Reichert,et al. Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin , 2007, The Journal of Neuroscience.
[139] K. Lohmann,et al. Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts , 2010, PloS one.
[140] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[141] T. Niki,et al. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. , 2004, Biochemical and biophysical research communications.
[142] V. Daggett,et al. Molecular basis for the structural instability of human DJ-1 induced by the L166P mutation associated with Parkinson's disease. , 2008, Biochemistry.
[143] A. Singleton,et al. Parkinson's disease due to the R1441G mutation in Dardarin: A founder effect in the basques , 2006, Movement disorders : official journal of the Movement Disorder Society.
[144] C. Lautier,et al. Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. , 2008, American journal of human genetics.
[145] Janel O. Johnson,et al. Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow‐up over 10 years , 2005, Movement disorders : official journal of the Movement Disorder Society.
[146] J. Ioannidis,et al. A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease , 2011, Neurobiology of Aging.
[147] Michael K. Hutchinson,et al. Translation initiator EIF4G1 mutations in familial Parkinson disease. , 2011, American journal of human genetics.
[148] C. Griesinger,et al. Familial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation* , 2005, Journal of Biological Chemistry.
[149] K. Reetz,et al. Phenotypic spectrum of PINK1‐associated parkinsonism in 15 mutation carriers from 1 family , 2007, Movement disorders : official journal of the Movement Disorder Society.
[150] Peter T. Lansbury,et al. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.
[151] M. Vidailhet,et al. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. , 2011, Human molecular genetics.
[152] M. Farrer,et al. α-Synuclein and Parkinson disease susceptibility , 2007, Neurology.
[153] K. Kaestner,et al. A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism , 2012, PloS one.
[154] J. Nutt,et al. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. , 2006, American journal of human genetics.
[155] N. Wood,et al. PINK1 (PARK6) associated Parkinson disease in Ireland , 2004, Neurology.
[156] N. Brüggemann,et al. Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. , 2012, Archives of neurology.
[157] P. Pollak,et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.
[158] A. Björklund,et al. NURR1 in Parkinson disease—from pathogenesis to therapeutic potential , 2013, Nature Reviews Neurology.
[159] M. Farrer,et al. A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. , 2009, Parkinsonism & related disorders.
[160] Irene Litvan,et al. Lrrk2 and Lewy body disease , 2006, Annals of neurology.
[161] Wyeth W Wasserman,et al. DNAJC13 mutations in Parkinson disease. , 2014, Human molecular genetics.
[162] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[163] Vladimir Makarov,et al. The Sac1 Domain of SYNJ1 Identified Mutated in a Family with Early‐Onset Progressive Parkinsonism with Generalized Seizures , 2013, Human mutation.
[164] Patrick A. Lewis,et al. Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus , 2011, Nature communications.
[165] J. Ioannidis,et al. A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants , 2012, Journal of Medical Genetics.
[166] Aldo Quattrone,et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. , 2006, JAMA.
[167] M. Farrer,et al. Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.
[168] J. Hardy,et al. Study of the genetic variability in a Parkinson's Disease gene: EIF4G1 , 2012, Neuroscience Letters.
[169] J. Nutt,et al. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.
[170] M. Farrer,et al. A Swedish family with de novo α -synuclein A53T mutation: Evidence for early cortical dysfunction , 2009 .
[171] O. Levy,et al. The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[172] Ying Sun,et al. Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies , 2011, Cell.
[173] A. Ziegler,et al. From GWAS to clinical utility in Parkinson's disease , 2011, The Lancet.
[174] N. Hattori,et al. Leucine-Rich Repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population , 2007, Neuroreport.
[175] R. Nussbaum,et al. Parkinsonism among Gaucher disease carriers , 2004, Journal of Medical Genetics.
[176] U Inserm,et al. Causal relation between α synuclein gene duplication and familial Parkinson’s disease , 2005 .
[177] Beate Ritz,et al. α-Synuclein Genetic Variants Predict Faster Motor Symptom Progression in Idiopathic Parkinson Disease , 2012, PloS one.
[178] V. Lee,et al. Alpha-synuclein: normal function and role in neurodegenerative diseases. , 2004, Current topics in developmental biology.
[179] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[180] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[181] Daniel Offen,et al. DJ-1 protects against dopamine toxicity , 2009, Journal of Neural Transmission.
[182] A. Singleton,et al. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: Phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations , 2009, Movement disorders : official journal of the Movement Disorder Society.
[183] Christine Klein,et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.
[184] M. Farrer,et al. Expanding the clinical phenotype of SNCA duplication carriers , 2009, Movement disorders : official journal of the Movement Disorder Society.
[185] M. Cookson,et al. Genetic neuropathology of Parkinson's disease. , 2008, International journal of clinical and experimental pathology.
[186] A. Brice,et al. A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson’s disease , 2009, neurogenetics.
[187] B. Jeon,et al. α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.
[188] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[189] A. Bentivoglio,et al. PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.
[190] J. Jankovic,et al. Motor symptoms in Parkinson's disease. , 2007, Handbook of clinical neurology.
[191] Glenda M. Halliday,et al. Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation , 2001 .
[192] A. Lang,et al. The curious case of phenocopies in families with genetic Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.